Vertex Pharmaceuticals Inc (VRTX)
450.38
-0.85
(-0.19%)
USD |
NASDAQ |
Nov 21, 16:00
450.38
0.00 (0.00%)
After-Hours: 18:27
Vertex Pharmaceuticals Price to Book Value: 7.420 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.434 |
| November 19, 2024 | 7.381 |
| November 18, 2024 | 7.694 |
| November 15, 2024 | 7.673 |
| November 14, 2024 | 7.974 |
| November 13, 2024 | 8.149 |
| November 12, 2024 | 8.073 |
| November 11, 2024 | 8.266 |
| November 08, 2024 | 8.514 |
| November 07, 2024 | 8.278 |
| November 06, 2024 | 8.133 |
| November 05, 2024 | 8.236 |
| November 04, 2024 | 7.790 |
| November 01, 2024 | 7.762 |
| October 31, 2024 | 7.842 |
| October 30, 2024 | 7.834 |
| October 29, 2024 | 7.756 |
| October 28, 2024 | 7.855 |
| October 25, 2024 | 7.877 |
| October 24, 2024 | 7.781 |
| October 23, 2024 | 7.751 |
| October 22, 2024 | 7.831 |
| October 21, 2024 | 7.883 |
| October 18, 2024 | 7.964 |
| October 17, 2024 | 8.224 |
| Date | Value |
|---|---|
| October 16, 2024 | 8.034 |
| October 15, 2024 | 7.986 |
| October 14, 2024 | 7.994 |
| October 11, 2024 | 7.943 |
| October 10, 2024 | 7.851 |
| October 09, 2024 | 7.716 |
| October 08, 2024 | 7.568 |
| October 07, 2024 | 7.397 |
| October 04, 2024 | 7.508 |
| October 03, 2024 | 7.479 |
| October 02, 2024 | 7.620 |
| October 01, 2024 | 7.746 |
| September 30, 2024 | 7.669 |
| September 27, 2024 | 8.086 |
| September 26, 2024 | 8.091 |
| September 25, 2024 | 8.067 |
| September 24, 2024 | 8.088 |
| September 23, 2024 | 8.036 |
| September 20, 2024 | 8.122 |
| September 19, 2024 | 8.348 |
| September 18, 2024 | 8.283 |
| September 17, 2024 | 8.407 |
| September 16, 2024 | 8.55 |
| September 13, 2024 | 8.479 |
| September 12, 2024 | 8.362 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.758
Minimum
Oct 05 2021
11.87
Maximum
Jun 23 2020
6.907
Average
6.200
Median
Jul 05 2022
Price to Book Value Benchmarks
| Gilead Sciences Inc | 6.058 |
| Eli Lilly and Co | 49.99 |
| Bristol-Myers Squibb Co | 6.891 |
| Moderna Inc | 1.234 |
| Pfizer Inc | 1.543 |
Price to Book Value Related Metrics
| PS Ratio | 11.03 |
| Price | 450.38 |
| Earnings Yield | -0.44% |
| Market Cap | 115.99B |
| Operating PE Ratio | 27.65 |
| Normalized PE Ratio | 38.08 |